JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature
Abstract Background Polycythemia vera (PV) is characterized by red cell mass expansion in the peripheral blood and can be complicated with thrombosis, bleeding, evolution to acute myeloid leukemia (AML) or a fibrotic phase. Paroxysmal nocturnal hemoglobinuria (PNH) in an acquired clonal haematopoiet...
Main Authors: | Sevastianos Chatzidavid, Nefeli Giannakopoulou, Panagiotis Theodorou Diamantopoulos, Eleni Gavriilaki, Panagiota Katsiampoura, Eleftheria Lakiotaki, Stratigoula Sakellariou, Nora-Athina Viniou, Georgios Dryllis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-021-00269-8 |
Similar Items
-
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
by: Vaddi K, et al.
Published: (2016-05-01) -
Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera
by: Benevolo G, et al.
Published: (2023-11-01) -
Obstructive Sleep Apnea Does Not Exclude Polycythemia Vera: A Case Report
by: Mohammad S. Afana, et al.
Published: (2024-01-01) -
JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
by: Bárbara da Costa Reis Monte-Mór, et al.
Published: (2007-03-01) -
Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data
by: Dilan Paranagama, et al.
Published: (2018-07-01)